{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:13:46Z","timestamp":1789517626765,"version":"build-2803163510"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2013,3,30]],"date-time":"2013-03-30T00:00:00Z","timestamp":1364601600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1007\/s00702-013-1011-3","type":"journal-article","created":{"date-parts":[[2013,3,29]],"date-time":"2013-03-29T07:25:02Z","timestamp":1364541902000},"page":"927-935","source":"Crossref","is-referenced-by-count":40,"title":["Role of serotonin 5-HT2A receptors in the development of cardiac hypertrophy in response to aortic constriction in mice"],"prefix":"10.1007","volume":"120","author":[{"given":"O.","family":"Lairez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Cognet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Schaak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Calise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Guilbeau-Frugier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Parini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Mialet-Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,3,30]]},"reference":[{"issue":"4","key":"1011_CR1","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.yjmcc.2011.01.012","volume":"51","author":"ME Anderson","year":"2011","unstructured":"Anderson ME, Brown JH, Bers DM (2011) CaMKII in myocardial hypertrophy and heart failure. J Mol Cell Cardiol 51(4):468\u2013473","journal-title":"J Mol Cell Cardiol"},{"issue":"6","key":"1011_CR2","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.yjmcc.2007.08.019","volume":"43","author":"T Brattelid","year":"2007","unstructured":"Brattelid T, Qvigstad E, Birkeland JA, Swift F, Bekkevold SV, Krobert KA, Sejersted OM, Skomedal T, Osnes JB, Levy FO, Sjaastad I (2007) Serotonin responsiveness through 5-HT2A and 5-HT4 receptors is differentially regulated in hypertrophic and failing rat cardiac ventricle. J Mol Cell Cardiol 43(6):767\u2013779","journal-title":"J Mol Cell Cardiol"},{"issue":"9","key":"1011_CR3","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.1073\/pnas.0308723101","volume":"101","author":"E Bush","year":"2004","unstructured":"Bush E, Fielitz J, Melvin L, Martinez-Arnold M, McKinsey TA, Plichta R, Olson EN (2004) A small molecular activator of cardiac hypertrophy uncovered in a chemical screen for modifiers of the calcineurin signaling pathway. Proc Natl Acad Sci USA 101(9):2870\u20132875","journal-title":"Proc Natl Acad Sci USA"},{"issue":"Suppl 1","key":"1011_CR4","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/BF00053431","volume":"4","author":"C Cobo","year":"1990","unstructured":"Cobo C, Alcocer L, Chavez A (1990) Effects of ketanserin on left ventricular hypertrophy in hypertensive patients. Cardiovasc Drugs Ther 4(Suppl 1):73\u201376","journal-title":"Cardiovasc Drugs Ther"},{"issue":"5","key":"1011_CR5","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.molmed.2004.03.007","volume":"10","author":"F Cote","year":"2004","unstructured":"Cote F, Fligny C, Fromes Y, Mallet J, Vodjdani G (2004) Recent advances in understanding serotonin regulation of cardiovascular function. Trends Mol Med 10(5):232\u2013238","journal-title":"Trends Mol Med"},{"issue":"8","key":"1011_CR6","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1161\/01.CIR.0000139856.20505.57","volume":"110","author":"F Jaffre","year":"2004","unstructured":"Jaffre F, Callebert J, Sarre A, Etienne N, Nebigil CG, Launay JM, Maroteaux L, Monassier L (2004) Involvement of the serotonin 5-HT2B receptor in cardiac hypertrophy linked to sympathetic stimulation: control of interleukin-6, interleukin-1beta, and tumor necrosis factor-alpha cytokine production by ventricular fibroblasts. Circulation 110(8):969\u2013974","journal-title":"Circulation"},{"issue":"1","key":"1011_CR7","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1161\/CIRCRESAHA.108.180976","volume":"104","author":"F Jaffre","year":"2009","unstructured":"Jaffre F, Bonnin P, Callebert J, Debbabi H, Setola V, Doly S, Monassier L, Mettauer B, Blaxall BC, Launay JM, Maroteaux L (2009) Serotonin and angiotensin receptors in cardiac fibroblasts coregulate adrenergic-dependent cardiac hypertrophy. Circ Res 104(1):113\u2013123","journal-title":"Circ Res"},{"issue":"2","key":"1011_CR8","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/S0022-3565(25)12956-X","volume":"277","author":"JH Kehne","year":"1996","unstructured":"Kehne JH, Baron BM, Carr AA, Chaney SF, Elands J, Feldman DJ, Frank RA, van Giersbergen PL, McCloskey TC, Johnson MP, McCarty DR, Poirot M, Senyah Y, Siegel BW, Widmaier C (1996) Preclinical characterization of the potential of the putative atypical antipsychotic MDL 100,907 as a potent 5-HT2A antagonist with a favorable CNS safety profile. J Pharmacol Exp Ther 277(2):968\u2013981","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"1011_CR9","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s00210-004-0951-4","volume":"370","author":"AR Knight","year":"2004","unstructured":"Knight AR, Misra A, Quirk K, Benwell K, Revell D, Kennett G, Bickerdike M (2004) Pharmacological characterisation of the agonist radioligand binding site of 5-HT(2A), 5-HT(2B) and 5-HT(2C) receptors. Naunyn Schmiedebergs Arch Pharmacol 370(2):114\u2013123","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"4","key":"1011_CR10","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.yjmcc.2008.12.017","volume":"46","author":"O Lairez","year":"2009","unstructured":"Lairez O, Calise D, Bianchi P, Ordener C, Spreux-Varoquaux O, Guilbeau-Frugier C, Escourrou G, Seif I, Roncalli J, Pizzinat N, Galinier M, Parini A, Mialet-Perez J (2009) Genetic deletion of MAO-A promotes serotonin-dependent ventricular hypertrophy by pressure overload. J Mol Cell Cardiol 46(4):587\u2013595","journal-title":"J Mol Cell Cardiol"},{"issue":"2","key":"1011_CR11","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.cardiores.2006.08.003","volume":"72","author":"YJ Liang","year":"2006","unstructured":"Liang YJ, Lai LP, Wang BW, Juang SJ, Chang CM, Leu JG, Shyu KG (2006) Mechanical stress enhances serotonin 2B receptor modulating brain natriuretic peptide through nuclear factor-kappaB in cardiomyocytes. Cardiovasc Res 72(2):303\u2013312","journal-title":"Cardiovasc Res"},{"issue":"5","key":"1011_CR12","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1172\/JCI38022","volume":"119","author":"H Ling","year":"2009","unstructured":"Ling H, Zhang T, Pereira L, Means CK, Cheng H, Gu Y, Dalton ND, Peterson KL, Chen J, Bers D, Brown JH (2009) Requirement for Ca2+\/calmodulin-dependent kinase II in the transition from pressure overload-induced cardiac hypertrophy to heart failure in mice. J Clin Invest 119(5):1230\u20131240","journal-title":"J Clin Invest"},{"issue":"12","key":"1011_CR13","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1038\/sj.npp.1300762","volume":"30","author":"GJ Marek","year":"2005","unstructured":"Marek GJ, Martin-Ruiz R, Abo A, Artigas F (2005) The selective 5-HT2A receptor antagonist M100907 enhances antidepressant-like behavioral effects of the SSRI fluoxetine. Neuropsychopharmacology 30(12):2205\u20132215","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"1011_CR14","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s00702-007-0695-7","volume":"114","author":"J Mialet-Perez","year":"2007","unstructured":"Mialet-Perez J, Bianchi P, Kunduzova O, Parini A (2007) New insights on receptor-dependent and monoamine oxidase-dependent effects of serotonin in the heart. J Neural Transm 114(6):823\u2013827","journal-title":"J Neural Transm"},{"issue":"2","key":"1011_CR15","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.yjmcc.2011.07.019","volume":"52","author":"J Mialet-Perez","year":"2012","unstructured":"Mialet-Perez J, D\u2019Angelo R, Villeneuve C, Ordener C, Negre-Salvayre A, Parini A, Vindis C (2012) Serotonin 5-HT2A receptor-mediated hypertrophy is negatively regulated by caveolin-3 in cardiomyoblasts and neonatal cardiomyocytes. J Mol Cell Cardiol 52(2):502\u2013510","journal-title":"J Mol Cell Cardiol"},{"issue":"2","key":"1011_CR16","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1161\/HYPERTENSIONAHA.107.105551","volume":"52","author":"L Monassier","year":"2008","unstructured":"Monassier L, Laplante MA, Jaffre F, Bousquet P, Maroteaux L, de Champlain J (2008) Serotonin 5-HT(2B) receptor blockade prevents reactive oxygen species-induced cardiac hypertrophy in mice. Hypertension 52(2):301\u2013307","journal-title":"Hypertension"},{"issue":"4","key":"1011_CR17","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1159\/000205962","volume":"113","author":"RR Nigmatullina","year":"2009","unstructured":"Nigmatullina RR, Kirillova VV, Jourjikiya RK, Mukhamedyarov MA, Kudrin VS, Klodt PM, Palotas A (2009) Disrupted serotonergic and sympathoadrenal systems in patients with chronic heart failure may serve as new therapeutic targets and novel biomarkers to assess severity, progression and response to treatment. Cardiology 113(4):277\u2013286","journal-title":"Cardiology"},{"issue":"3","key":"1011_CR18","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1161\/01.RES.0000176970.22603.8d","volume":"97","author":"E Qvigstad","year":"2005","unstructured":"Qvigstad E, Sjaastad I, Brattelid T, Nunn C, Swift F, Birkeland JA, Krobert KA, Andersen GO, Sejersted OM, Osnes JB, Levy FO, Skomedal T (2005) Dual serotonergic regulation of ventricular contractile force through 5-HT2A and 5-HT4 receptors induced in the acute failing heart. Circ Res 97(3):268\u2013276","journal-title":"Circ Res"},{"issue":"18","key":"1011_CR19","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/j.lfs.2006.06.026","volume":"79","author":"KG Rajesh","year":"2006","unstructured":"Rajesh KG, Suzuki R, Maeda H, Murio Y, Sasaguri S (2006) 5-HT2 receptor blocker sarpogrelate prevents downregulation of antiapoptotic protein Bcl-2 and protects the heart against ischemia-reperfusion injury. Life Sci 79(18):1749\u20131755","journal-title":"Life Sci"},{"issue":"4","key":"1011_CR20","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1139\/Y08-005","volume":"86","author":"SK Sanganalmath","year":"2008","unstructured":"Sanganalmath SK, Barta J, Takeda N, Kumamoto H, Dhalla NS (2008) Antiplatelet therapy mitigates cardiac remodeling and dysfunction in congestive heart failure due to myocardial infarction. Can J Physiol Pharmacol 86(4):180\u2013189","journal-title":"Can J Physiol Pharmacol"},{"issue":"2","key":"1011_CR21","doi-asserted-by":"crossref","first-page":"H821","DOI":"10.1152\/ajpheart.00345.2009","volume":"297","author":"C Villeneuve","year":"2009","unstructured":"Villeneuve C, Caudrillier A, Ordener C, Pizzinat N, Parini A, Mialet-Perez J (2009) Dose-dependent activation of distinct hypertrophic pathways by serotonin in cardiac cells. Am J Physiol Heart Circ Physiol 297(2):H821\u2013H828","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"1","key":"1011_CR22","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.bbrc.2009.12.001","volume":"391","author":"C Vindis","year":"2010","unstructured":"Vindis C, D\u2019Angelo R, Mucher E, Negre-Salvayre A, Parini A, Mialet-Perez J (2010) Essential role of TRPC1 channels in cardiomyoblasts hypertrophy mediated by 5-HT2A serotonin receptors. Biochem Biophys Res Commun 391(1):979\u2013983. doi: 10.1016\/j.bbrc.2009.12.001","journal-title":"Biochem Biophys Res Commun"},{"issue":"Suppl 1","key":"1011_CR23","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/BF00053433","volume":"4","author":"GP Vyssoulis","year":"1990","unstructured":"Vyssoulis GP, Karpanou EA, Pitsavos CE, Paleologos AA, Kourtis TK, Toutouzas PK (1990) Left ventricular hypertrophy regression and function changes with ketanserin in elderly hypertensives. Cardiovasc Drugs Ther 4(Suppl 1):81\u201384","journal-title":"Cardiovasc Drugs Ther"},{"issue":"6","key":"1011_CR24","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1042\/CS20040310","volume":"108","author":"HH Xie","year":"2005","unstructured":"Xie HH, Shen FM, Cao YB, Li HL, Su DF (2005) Effects of low-dose ketanserin on blood pressure variability, baroreflex sensitivity and end-organ damage in spontaneously hypertensive rats. Clin Sci (Lond) 108(6):547\u2013552","journal-title":"Clin Sci (Lond)"},{"issue":"4","key":"1011_CR25","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.yjmcc.2008.12.019","volume":"46","author":"S Yabanoglu","year":"2009","unstructured":"Yabanoglu S, Akkiki M, S\u00e9gu\u00e9las MH, Mialet-Perez J, Parini A, Pizzinat N (2009) Platelet derived serotonin drives the activation of rat cardiac fibroblasts by 5-HT2A receptors. J Mol Cell Cardiol 46(4):518\u2013525","journal-title":"J Mol Cell Cardiol"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-013-1011-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00702-013-1011-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-013-1011-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T02:34:48Z","timestamp":1745980488000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00702-013-1011-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,30]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["1011"],"URL":"https:\/\/doi.org\/10.1007\/s00702-013-1011-3","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,30]]}}}